(CCU) Compania Cervecerias Unidas - Overview
Sector: Consumer Defensive | Industry: Beverages - Brewers | Exchange: NYSE (USA) | Market Cap: 2.296m USD | Total Return: -9.9% in 12m
Industry Rotation: +6.0
Avg Turnover: 2.20M USD
Peers RS (IBD): 32.7
EPS Trend: 35.4%
Qual. Beats: 0
Rev. Trend: 23.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Compañía Cervecerías Unidas S.A. (CCU) is a Chile-based, diversified beverage group operating across Chile, Argentina, Bolivia, Colombia, Paraguay, and Uruguay through three segments: Chile, International Business, and Wine. Its portfolio spans beers (Heineken, Bavaria, Amstel, etc.), wines (Viña Santa Helena, Graffigna), soft drinks, water, energy drinks, and spirits, covering more than 150 brands.
In FY 2025 CCU reported revenue of $2.34 billion, an EBITDA margin of 15.2 % and net income of $210 million, delivering a dividend yield near 3.5 % while maintaining a debt-to-equity ratio of 0.68. The company’s earnings were bolstered by a 6 % rise in premium-beer sales, offset by modest volume declines in the mass-market segment driven by Chile’s high inflation and a weaker peso.
Key drivers for CCU include regional consumer-spending trends, especially the shift toward higher-margin craft and premium beverages, and commodity cost pressures on barley and aluminum cans. Additionally, the company benefits from strategic partnerships with global brewers (Heineken, Molson Coors) that provide access to new product launches and distribution efficiencies.
For deeper insights, you might explore ValueRay’s analyst notes.
- Currency fluctuations impact international business segment revenue
- Economic stability in Chile drives domestic beverage sales
- Raw material cost volatility pressures profit margins
- Regulatory changes in alcohol sales affect market access
- Competition from global beverage brands erodes market share
| Net Income: 115.38b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.16 > 1.0 |
| NWC/Revenue: 24.89% < 20% (prev 31.37%; Δ -6.48% < -1%) |
| CFO/TA 0.06 > 3% & CFO 215.34b > Net Income 115.38b |
| Net Debt (806.90b) to EBITDA (269.76b): 2.99 < 3 |
| Current Ratio: 1.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (184.8m) vs 12m ago 0.00% < -2% |
| Gross Margin: 44.37% > 18% (prev 0.45%; Δ 4.39k% > 0.5%) |
| Asset Turnover: 74.36% > 50% (prev 72.80%; Δ 1.56% > 0%) |
| Interest Coverage Ratio: 3.67 > 6 (EBITDA TTM 269.76b / Interest Expense TTM 71.30b) |
| A: 0.19 (Total Current Assets 1515.43b - Total Current Liabilities 797.93b) / Total Assets 3761.95b |
| B: 0.27 (Retained Earnings 1025.07b / Total Assets 3761.95b) |
| C: 0.07 (EBIT TTM 261.41b / Avg Total Assets 3875.83b) |
| D: 0.69 (Book Value of Equity 1476.15b / Total Liabilities 2140.85b) |
| Altman-Z'' Score: 3.32 = A |
| DSRI: 1.12 (Receivables 499.92b/449.54b, Revenue 2882.19b/2904.57b) |
| GMI: 1.02 (GM 44.37% / 45.23%) |
| AQI: 1.20 (AQ_t 0.20 / AQ_t-1 0.16) |
| SGI: 0.99 (Revenue 2882.19b / 2904.57b) |
| TATA: -0.03 (NI 115.38b - CFO 215.34b) / TA 3761.95b) |
| Beneish M-Score: -2.83 (Cap -4..+1) = A |
Over the past week, the price has changed by +4.85%, over one month by +4.50%, over three months by -11.44% and over the past year by -9.87%.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 3
- StrongSell: 0
| Analysts Target Price | 11.6 | -7.9% |
P/E Trailing = 17.7143
P/E Forward = 10.917
P/S = 0.6896
P/B = 1.3632
P/EG = 1.7275
Revenue TTM = 2882.19b CLP
EBIT TTM = 261.41b CLP
EBITDA TTM = 269.76b CLP
Long Term Debt = 1032.20b CLP (from longTermDebt, last quarter)
Short Term Debt = 199.09b CLP (from shortTermDebt, last quarter)
Debt = 1327.57b CLP (from shortLongTermDebtTotal, last quarter)
Net Debt = 806.90b CLP (from netDebt column, last quarter)
Enterprise Value = 2846.55b CLP (2049.60b + Debt 1327.57b - CCE 530.62b)
Interest Coverage Ratio = 3.67 (Ebit TTM 261.41b / Interest Expense TTM 71.30b)
EV/FCF = 21.54x (Enterprise Value 2846.55b / FCF TTM 132.14b)
FCF Yield = 4.64% (FCF TTM 132.14b / Enterprise Value 2846.55b)
FCF Margin = 4.58% (FCF TTM 132.14b / Revenue TTM 2882.19b)
Net Margin = 4.00% (Net Income TTM 115.38b / Revenue TTM 2882.19b)
Gross Margin = 44.37% ((Revenue TTM 2882.19b - Cost of Revenue TTM 1603.22b) / Revenue TTM)
Gross Margin QoQ = 46.01% (prev 42.50%)
Tobins Q-Ratio = 0.76 (Enterprise Value 2846.55b / Total Assets 3761.95b)
Interest Expense / Debt = 1.51% (Interest Expense 20.04b / Debt 1327.57b)
Taxrate = 21.28% (17.35b / 81.55b)
NOPAT = 205.79b (EBIT 261.41b * (1 - 21.28%))
Current Ratio = 1.90 (Total Current Assets 1515.43b / Total Current Liabilities 797.93b)
Debt / Equity = 0.90 (Debt 1327.57b / totalStockholderEquity, last quarter 1476.15b)
Debt / EBITDA = 2.99 (Net Debt 806.90b / EBITDA 269.76b)
Debt / FCF = 6.11 (Net Debt 806.90b / FCF TTM 132.14b)
Total Stockholder Equity = 1492.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.98% (Net Income 115.38b / Total Assets 3761.95b)
RoE = 7.73% (Net Income TTM 115.38b / Total Stockholder Equity 1492.17b)
RoCE = 10.36% (EBIT 261.41b / Capital Employed (Equity 1492.17b + L.T.Debt 1032.20b))
RoIC = 7.44% (NOPAT 205.79b / Invested Capital 2764.36b)
WACC = 5.26% (E(2049.60b)/V(3377.17b) * Re(7.89%) + D(1327.57b)/V(3377.17b) * Rd(1.51%) * (1-Tc(0.21)))
Discount Rate = 7.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 86.02% ; FCFF base≈132.79b ; Y1≈128.73b ; Y5≈128.34b
[DCF] Fair Price = 16.4k (EV 3827.76b - Net Debt 806.90b = Equity 3020.86b / Shares 184.8m; r=6.0% [WACC]; 5y FCF grow -4.23% → 3.0% )
EPS Correlation: 35.42 | EPS CAGR: 654.2% | SUE: -1.94 | # QB: 0
Revenue Correlation: 22.96 | Revenue CAGR: 4.49% | SUE: -0.28 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.06 | Chg7d=+0.060 | Chg30d=+0.060 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.80 | Chg7d=-0.016 | Chg30d=-0.016 | Revisions Net=-1 | Growth EPS=+8.4% | Growth Revenue=+7.5%
EPS next Year (2027-12-31): EPS=0.92 | Chg7d=-0.027 | Chg30d=-0.027 | Revisions Net=-1 | Growth EPS=+15.2% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 7.9% - Earnings Yield 5.6%)
[Growth] Growth Spread = +2.6% (Analyst 4.9% - Implied 2.3%)